Kabra Drugs Announces Pharma Expansion, Defense AI Initiatives

Kabra Drugs Board approved phased expansion of pharmaceutical manufacturing and marketing through channel partners.
Company to pursue SCOMET license for AI-driven defense technologies and establish dedicated R&D facility in Chennai.
Appointed Mr. Alagiamanavalan as Independent Consultant for domestic and international defense projects.